secwatch.observer — SEC 8-K summary
======================================

Issuer:     KIORA PHARMACEUTICALS INC (KPRX)
CIK:        0001372514
Form:       8-K
Filed at:   2022-02-14T23:59:59+00:00
Accession:  0001104659-22-023200
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Kiora Pharmaceuticals CFO Sarah Romano resigns effective Feb 25, 2022
---------------------------------------------------------------------

- CFO Sarah Romano will resign effective Feb 25, 2022 to pursue another opportunity.
- Resignation not due to any disagreement with the Company's operations, policies or practices.
- No successor has been announced as of the filing date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1372514/000110465922023200/0001104659-22-023200-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1372514/000110465922023200/tm226703d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-023200

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer